Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
What was recalled
Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01
Recalling firm
Boehringer Ingelheim Pharmaceuticals, Inc.
NDC code
0597-0030-01
Origin
CT, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0007-2018
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.